This study characterized gene transfer into both normal mals showed a significant (P р 0.05) increase in the numand injured adult rat dorsal spinal cord using first (E1−/E3−) ber of LacZ-positive cells not displaying cytopathology. In or second (E1−/E2A 125 /E3−, temperature-sensitive; ts) these animals, a concomitant reduction in numbers of generation of replication-defective adenoviral (Ad) vectors.
Introduction
The use of gene therapy for replacement of clinically relevant molecules in both acquired and inherited neurological disorders is currently under extensive investigation. [1] [2] [3] In the spinal cord, in vivo gene transfer of molecules with potential therapeutic value has been recognized as a viable method for inducing functional recovery after injury. [4] [5] [6] Replication-defective recombinant adenoviruses are commonly used as gene transfer vectors because of their ability to transduce both neurons and glial cells efficiently. 7 However, expression of the transgene is transient 7, 8 and most likely due to a cellular immune response by the host. This response is mediated by CD4
+ and CD8 + T lymphocytes. [8] [9] [10] [11] In peripheral organs, attempts to overcome this limitation have resulted in the design of improved adenoviral vectors with reduced immunogenicity, [12] [13] [14] immunoregulatory strategies aimed at reducing the inflammatory response, 12, 15 and a combination of these two strategies.
additional deletions (ie, E3−) enhance the capacity of the vector for transgene accommodation. 13, 14 In addition, adenoviral vectors bearing point mutations in the E2A region are less able to synthesize late viral proteins if grown at nonpermissive temperatures (temperaturesensitive, ts). 16 This mutation is thought to render the Ad ts less immunogenic and therefore, potentially capable of improving transgene stability. 13 However, the evidence regarding their immunogenicity and induced transgene persistence after peripheral administration is contradictory. 17, 18 Furthermore, the performance of this vector for CNS gene transfer as well as transgene persistence in the injured CNS have not been evaluated.
Enhanced transgene stability has been reported in several studies in which the immune response against the viral vectors is blocked using monoclonal antibodies to either directly deplete the CD4 cells 19, 20 or to perturb T cell costimulatory pathways. 21 However, most of these studies have been performed in mice and evaluation of these immunomodulatory strategies after viral transfection in the central nervous system is lacking.
The present study characterized gene transfer into the normal and the injured adult rat dorsal spinal cord mediated by first (E1−/E3− Ad) and second (E1−/E2A 125 /E3− Ad ts ) generation adenoviral vectors. The effect of combining improved adenoviral vectors and immune blockade of CD4 and CD45 lymphocytic recep-tors, a novel immunosuppresant regimen, on transgene stability was also investigated. In addition, functionality of the transduced dorsal spinal cord was evaluated by assessing pain perception in treated animals. Although little benefit was observed with the use of the Ad ts vector, immunosuppression aimed at the transient depletion of T lymphocytes ensured long-term transgene expression in the adult rat spinal cord without affecting normal pain sensation. Furthermore, transfection efficiency and persistence does not appear to be affected by injury to sensory afferents of the spinal cord.
Results
Transduction efficiency and persistence Seven days after adenoviral administration, numerous transduced cells were demonstrated by ␤-galactosidase histochemistry in both normal and injured animals injected with a total of 3.2 l (5 × 10 6 p.f.u./l) of LacZ/Ad ts ( Figure 1 ). In these animals, LacZ-positive cells were observed to be mostly limited to the dorsal horn, including cells at the dorsal root entry zone; the PNS-CNS transition area at which dorsal root fibers enter the spinal cord ( Figure 1A ). Although LacZ-expressing cells were not observed in the contralateral side, ventral motor neurons ipsilateral to the injection were commonly transduced. Intense ␤-galactosidase staining could only be observed throughout the L4-L5 lumbar levels ( Figure  1B) , and in the distal and the proximal segments of L3 and L6, respectively. As previously reported, 6 colocalization of human ␤-galactosidase with either neurofilament or glial fibrillary acidic proteins by double immunofluorescence revealed numerous transfected astrocytes, mostly located in the dorsal horn; whereas, transduced neurons were located primarily in the ventral horn. Similar transgene expression was achieved at this time, independent of adenoviral vector type (not shown), immunomodulation (Figures 2A and D) , or injury to L4-L5 dorsal roots ( Figure 1A) .
A dramatic qualitative reduction in ␤-galactosidase staining was evident at 21 days after transfection with the two adenoviral vectors ( Figure 2B ) compared with that observed at 7 days after treatment ( Figure 2A ). In both LacZ/Ad-and LacZ/Ad ts -treated groups, the majority of the ␤-galactosidase-expressing cells were spherical and lacked stained processes, suggestive of ongoing cytopathology (Figures 3A, B and inserts in Figure 4) . In contrast, animals treated with CD4/CD45 antisera showed numerous ␤-galactosidase-positive cells ( Figure 2E ) with clear morphological characteristics of either astrocytes ( Figure 3C ) or neurons ( Figure 3D ) and no visible evidence of cytopathology or tissue trauma. Similar results were observed in animals that were lesioned at the L4-L5 dorsal roots before LacZ/Ad ts and immunosuppression cotreatments (see Figure 5 ).
Quantitative analysis of the number of ␤-galactosidasepositive cells performed 21 days after LacZ adenovirus injection revealed a significant increase (F 1-6 = 11.01; P р 0.05) in the number of LacZ-expressing cells in animals treated with CD4/CD45 antisera (754 ± 77) compared with the number of LacZ-positive cells in immunocompetent animals (431 ± 144). The LacZ construct used in this study lacked a nuclear localization signal and allowed visualization of ␤-galactosidase in the cytoplasm, which rendered a Golgi-like staining of perikarya and processes in the transduced cells (see Figure 3C and D). Evaluation of the percentage of LacZ-expressing cells showing no signs of cytopathology indicated that only a minor proportion of the ␤-galactosidase-positive cells were morphologically normal in nonimmunosuppressed animals, independently of the vector type or of dorsal root injury (Figure 5a ). In immunosuppressed LacZ/Ad ts -treated animals, however, the vast majority of the LacZ-positive cells showed normal morphological characteristics in both unlesioned and lesioned animals (Figure 5a ).
At 60 days after treatment, ␤-galactosidase-positive cells were observed in animals treated with CD4/CD45 antisera ( Figure 2F ) but not in those treated only with the LacZ adenoviruses ( Figure 2C ). Although LacZ-positive neurons and glia were observed at 60 days after transfection in immunosuppressed animals, ␤-galactosidase staining was most prominent in astrocytes. At this timepoint, the transduced cells showed LacZ-positive staining in the processes, indicative of normal morphology. Some neuronal staining, however, appeared granular within the cytoplasm. Because no abnormalities were recognized in these cells by phase-contrast microscopy, this may represent residual ␤-galactosidase in inclusion bodies after expression has stopped.
Inflammatory response
Examination of the immune response elicited by the adenoviral vectors was achieved by the immunocytochemical visualization of macrophages/microglia and CD4 + (helper) and CD8 + (cytotoxic) T cells in areas of ␤-galactosidase expression. Figure 4 illustrates the inflammatory response towards the LacZ-expressing cells at 21 days after transfection in animals that received
Figure 4 Photomicrographs of adjacent dorsal spinal cord sections of animals treated without or with adjuvant immunosuppression (IS). At 21 days after transfection, animals with no immunosuppressive treatment showed reduced numbers of ␤-galactosidase-positive cells that correlated with a concomitant increase in the number of inflammatory cells expressing ED-1, CD-4 and CD-8 receptor. In both LacZ/Ad and LacZ/Ad ts -treated animals, the vast majority of the ␤-galactosidase-expressing cells showed degenerative morphology (inserts). In contrast, expression of the ED-1, CD-4 and CD-8 receptors was minimally detected in immunosuppressed animals and appeared to correlate with LacZ expression in cells of normal morphology. Magnification ×100 and ×400 (inserts).
either the LacZ/Ad or the LacZ/Ad ts vectors, with or without immunosuppression. Antisera specific for the ED-1 (reactive macrophages/microglia), CD4 (W3-25), and CD8 (OX-8) receptors were used for cell type identification. In both LacZ/Ad-and LacZ/Ad ts -treated animals, the vast majority of the ␤-galactosidase-expressing cells showed degenerative morphology (see inserts in Figure 4 ) which correlated with areas of intense ED-1, CD4 and CD8 immunoreactivity, indicative of a strong immune response against the transduced cells. The
Figure 5 Animals that were either L4-L5-lesioned (L) or unlesioned (U), injected with LacZ/Ad or LacZ/Ad ts adenoviruses, or that received coadjuvant immunosuppressive treatment (IS), were quantitatively analyzed for both transgene expression (a) and inflammation (b). The proportion ␤-galactosidase-positive cells with visible processes (indicative of normal morphology) is shown in panel a, and the inflammatory response elicited by the transduced cells, as indicated by the ED-1 to LacZ ratio, in panel b. Cell numbers represent those quantified through a 900 m segment of the L4-5 spinal cord showing maximum LacZ expression. *, P р 0.05 compared either with immunosuppressed animals (a) or to the LacZ/U treatment group (b). Each bar represents the mean of two to four animals (± s.e.m.).
immune response in animals that received the LacZ/Ad ts vector appears qualitatively reduced when compared with those injected with the LacZ/Ad virus. Animals that received antilymphocyte monoclonal antibodies before transfection showed many transduced cells of normal morphology ( immune blockade compared with nonimmunosuppressed animals (911 ± 302). Numbers of reactive macrophages/microglia (ED-1+) at 21 days after transfection appeared to correlate inversely to the total number of LacZ-expressing cells. To illustrate this relationship, ED-1-positive cells were divided by the ␤-galactosidasepositive population in order to estimate the ED-1/LacZ ratio (Figure 5b) . A significant (P р 0.05) reduction in the number of macrophages/microglia per ␤-galactosidaseexpressing cell was observed in unlesioned animals injected with the LacZ/Ad ts (1.82 ± 0.21) compared with those observed in animals that received the LacZ/Ad vector (3.94 ± 0.38). Injury to the L4-L5 dorsal roots before transfection with the LacZ/Ad ts vector increased significantly (P р 0.05) the ED-1/LacZ ratio (3.88 ± 1.24). Immunosuppression, however, significantly reduced the ratio of ED-1 to LacZ-expressing cells in both normal (0.63 ± 0.14) and injured (0.62 ± 0.10) LacZ/Ad ts -treated animals (P р 0.05 for both comparisons).
Thermal nociception
In order to test whether normal function of the dorsal spinal cord is affected by either the constitutive expression of the transgene or the immune response after adenovirus-mediated transduction, pain perception was evaluated up to 30 days in animals treated with either LacZ/Ad or LacZ/Ad ts vectors. Nociception was determined by paw withdrawal latency (PWL) in response to a noxious thermal stimulus and expressed as left-to-right (control-to-experimental) ratios. Normal baseline PWL ratios (open circles, dashed line) were determined from untreated and unlesioned animals and averaged 1.06 ± 0.03 ( Figure 6 ). Untreated animals with L4-L5 dorsal root injury (open squares, dotted line) were used as anesthetic controls. The PWL ratios in this group averaged 2.89 ± 0.09 and were significantly higher (F 1-56 = 164.09; P р 0.0001) than those observed in unlesioned animals. All lesioned animals reached the default maximum stimulation time of the plantar test (20.7 s) without paw withdrawal, indicating no pain sensation. Adenovirus injection into the L4-L5 dorsal root entry zone with either the LacZ/Ad (filled triangles, solid line) or LacZ/Ad ts (filled circles, solid line) did not affect thermal nociception at any post-transfection time up to 30 days, independent of immunosuppressive cotreatment. The sensory deficit observed in injured animals injected with the LacZ/Ad ts vector (filled squares, solid line) was similar to that of untreated/lesioned animals (open squares, dotted line).
Discussion
Previous studies of adenovirus-mediated gene transfer into the CNS have employed first generation adenoviruses mostly at moderate-to-high adenoviral titers (5 × 10 6 -2 × 10 7 total p.f.u.), that appear to be required for highly efficient gene transfer. 11 However, at this high concentration, the majority of the CNS-transfected cells either cease transgene expression or degenerate due to an immune inflammatory response within 2 weeks after administration. 11, 22 The early phase of a biphasic immune response appears to be induced primarily by proteins of the viral capsid 10 and includes the activation of resident microglia, as well as infiltration of peripheral macrophages and helper CD4 + T lymphocytes into the transduced area.
7,10,11 Upon activation, microglia are known to up-regulate the expression of major histocompatibility complex I (MHC I), leukocyte common antigen (CD-45), and CD4 receptors, 23, 24 while infiltrating macrophages have been found to upregulate the expression of MHC II. 23 The early immune response is followed by a later adaptive phase involving the infiltration of cytotoxic (CD8 + ) T cells that may directly participate in the decline of transduced cells.
9,11
The generation of temperature-sensitive adenoviral vectors with reduced expression of late viral proteins when grown at nonpermissive temperatures 16 led to the prediction of a reduced immune response against this vector. However, the reported evidence of its immunogenicity and induced transgene persistence after peripheral administration is controversial. 17, 18 In this study, incorporation of the ts-125 mutation (E2A 125 ) into the adenoviral vector reduced the immunogenicity of the virus compared with the E1−/E3− vector, as indicated by the reduction in the immunocytochemical detection of macrophages/microglia and of both helper and cytotoxic T cells. However, the apparent reduced immunogenicity of the LacZ/Ad ts fails to enhance transgene stability significantly, as indicated by the complete transgene extinction observed in animals treated with either LacZ/Ad or LacZ/Ad ts 60 days after transfection. Lack of long-term transgene persistence by the LacZ/Ad ts vector may reflect incomplete blockade of viral protein synthesis at 37°C. Alternatively, since ablation of E2A gene has been reported to induce overexpression of E4 viral proteins, 18 a direct cytotoxic effect by unrestrained E4 expression cannot be ruled out. The latter possibility, however, seems less plausible since we observed no evidence of cytotoxicity in immunosuppressed animals treated with the Ad ts vector. Another possibility may be that the majority of the adenovirus-induced immune response is elicited at the time of the injection by proteins of the viral capsid, which are similar in the two vectors used in this study.
Although the potential use of adenovirus-mediated gene transfer into the injured spinal cord for therapeutic purposes has long been recognized, whether ongoing injury and/or repair mechanisms interfere with transfection efficiency and persistence remain to be determined. In the present study, we evaluated this possibility by testing transfection efficiency and persistence in animals in which the L4-L5 dorsal roots were injured before LacZ/Ad ts injection into the L4-L5 dorsal root entry zone. In these animals, transgene expression at 7 and 21 days after inoculation was similar to that observed in nonlesioned rats. Because injury to the dorsal roots is known to result in degeneration of axons in the dorsal horn and activation of microglia (see Figure 5b) , this observation suggests that acute damage to the spinal cord does not affect the efficacy or stability of adenovirusmediated gene transfer.
Immunoregulation
In peripheral organs, several immunoregulatory methods have proven to be effective in reducing the adenovirusinduced immune response, thus extending the transgene persistence. 15, 21 In particular, antibodies against the lymphocytic CD4 receptor have been shown to block the function of helper T cells transiently and to extend adenovirus-mediated transgene expression both in liver 12, 19 and in the lung. 25 Despite the privileged immune status of the CNS, adenoviral vectors have been shown to elicit inflammation and a T cell-mediated immune response against the transduced cells. 5, [8] [9] [10] [11] In the mouse brain, peripheral administration of monoclonal antibodies against the CD4 receptor eliminates the second inflammatory phase elicited by adenovirus. 9 However, this treatment resulted in no observable effect on transgene stability, presumably due to the low viral titers (1 × 10 6 p.f.u.) used in that study. 11 Conversely, general immunosuppression via cyclosporin A has been reported to enhance transgene persistence in the spinal cord. 5 The present study used a novel combination of monoclonal antibodies that, in addition to blocking CD4 (W3/25), 26 also targeted CD45 (MRC OX-22) 27 lymphocytic receptors to impede T cell activation better. The combined use of these two antibodies selectively recognize 94% of the helper T cells, a higher percentage than that achieved by each individual antiserum. 26 In addition, the importance of blocking the CD45 T cell receptors has recently been highlighted by the reported inability of CD45-deficient mice to mount an effective antiviral cytotoxic T cell response. 28 Here we report that 21 days after LacZ/Ad ts administration, immunosuppression with anti-CD4 and anti-CD45 resulted in a significant reduction of the inflammatory response, as indicated by low numbers of ED-1+ cells and infiltrating T cells, and numerous ␤-galactosidase-positive cells showing normal morphology. This immunosuppressive protocol resulted in transgene expression detectable up to 60 days after transfection, that correlated with reduced infiltration of CD4 + and CD8 + T lymphocytes. The comparative results of CD4 and CD4/CD45 immunosuppression protocols indicated an enhancement in transgene persistence achieved only with their combined use (data not shown). This is the first report on the use of wide-spectra T cell receptor blockade and on the use of immunosuppression for transgene stability in the rat nervous system. The transient immunosuppression protocol used in the present report lengthened the persistence of transgene expression in the spinal cord to a similar extent to that previously achieved by chronic immunosuppression using cyclosporin A. 5 Therefore, the use of monoclonal antibodies for immunoneutralization may represent a more appealing adjuvant for gene therapy.
Despite effective immunosuppression, progressive attenuation of transgene expression occurred, as indicated by the reduction in the number of transduced cells at 60 days after transfection. This observation is in agreement with previous reports and strongly suggests that noncytotoxic mechanisms, such as promoter downregulation, are involved in reduced expression of the transgene.
19,29
Lack of functional deleterious effect after adenovirusmediated gene transfer The use of adenoviral vectors for in vivo gene transfer may raise the concern that toxic or pathological effects inherent to the treatment, whether direct or indirect, could cause damage to the transduced area and consequentially result in perturbation or loss of function. 30 One of the primary aims in this study was to determine whether normal function of the spinal cord is preserved after adenovirus-mediated cell transduction. Neurons that relay pain and temperature information from peripheral sensors to higher regions of the brain are localized within the dorsal horn of the spinal cord. Insult to or degeneration of these neurons would lead to changes in nociception (hyperalgesia, allodynia or loss of function). 31 Evaluation of thermal nociceptive thresholds in animals that received injections of either E1−/E3− or E1−/E2A 125 /E3− defective adenoviruses encoding the LacZ cDNA indicated no change in nociceptive perception. Surprisingly, normal foot-withdrawal responses elicited by the radiant stimulus applied selectively to the pads of the injected side were observed in all animals, regardless of the adenoviral vector type. These results demonstrate that even in the event of a specific immune response against adenovirally transduced cells, the induced cytopathic effect does not alter normal pain sensory perception. It follows, therefore, that many of the dorsal sensory neurons were spared by the inflammatory response and remained capable of mediating nociception. This may be explained by the observation that in the spinal dorsal horn, astrocytes appear to be preferentially transduced over neurons by the adenoviral vectors. 6 It is also possible that transduced neurons may not be direct targets for the T cells since, unlike astrocytes and microglia, they do not appear to readily express the MHC epitopes upon viral infection. 32 In immunosuppressed animals, the enhanced persistence of the transgene also did not alter nociception. This result is consistent with our previous report that adenoviral transduction of dorsal root ganglia neurons do not affect their physiological function, despite constitutive expression of the green fluorescent protein. 33 In summary, the results of the present study indicate that: (1) similar transduction efficiency and transgene stability can be achieved in animals with normal or injured spinal cords; (2) gene therapy to the CNS may benefit from the combined use of improved adenoviral vectors and adjuvant immunomodulation aimed at both phases of the inflammatory response; and (3) persistent LacZ expression in the spinal cord does not interfere with normal neural function, even in the event of an inflammatory response in the transduced area. Taken together, these results provide further support for the use of adenoviral vectors for gene transfer of molecules with therapeutic value aimed at re-establishing spinal cord function after injury or disease.
Materials and methods
Animals Adult (250-350 g) female Sprague-Dawley rats (Harlan Sprague Dawley, Indianapolis, IN, USA) were used in this study. Twelve animals were used to test the effect of the adenovirus vector type (E1−/E3− or E1−/E2A 125 /E3−; n = 6 per vector). In addition, 12 rats treated with the LacZ/Ad ts virus were used to evaluate the effect of immunosuppression in transgene persistence. Half of the animals treated with LacZ/Ad ts vector were lesioned at the L4-L5 dorsal sensory afferents. Five additional animals, either unlesioned (n = 3) or injured (n = 2), but without viral or immunosuppressive treatments were included as controls.
Thermal nociception was evaluated using the Basile (UGO BASILE, Comerio, Italy) plantar test device. 34 This apparatus uses a localized infrared light as a heat source to stimulate selectively the plantar surface of each hind paw. This device also automatically measures in seconds the latency for paw withdrawal in response to the noxious stimulus. In the present study, the infrared intensity was set at 50°C, a temperature that has been shown to discriminate neuropathic pain induced by unilateral lesions to peripheral nerves. 35 Three repeated measurements of paw withdrawal latencies were taken at 15 
Construction of adenoviral vectors
E1/E3-deficient LacZ adenovirus: Replication-defective recombinant adenoviruses were constructed as described by Bett and colleagues. 36 Briefly, the coding region of the LacZ gene was inserted into a modified pXCJL vector (gift from Dr F Graham, McMaster University, Toronto, Canada) that contains a Rous sarcoma virus long terminal repeat promoter and a bovine growth hormone polyadenylation signal (pXCRSV). 33 Viral particles lacking the E1 and E3 regions were obtained by cotransfecting equimolar concentrations of the LacZ/pXCRSV plasmid and the pBHG11 adenoviral genomic vector (Microbix, Toronto, Canada) into 293 cells using a liposomal delivery system (DOTAP; Boehringer Mannheim, Indianapolis, IN, USA). Successful recombinants were identified by their cytopathic effect on the 293 cells and confirmed by positive ␤-galactosidase histochemistry. Adenovirus containing the proper inserts were plaquepurified, propagated in 293 cells, and purified twice over cesium chloride gradients. Lack of wild-type contamination was confirmed by PCR using primers complimentary to the E1A region. 37 The physical number of viral particles was determined by optical absorbance 38 and the number of infectious particles estimated by counting crystal violet-stained plaques using the agarose overlay method. The titer of this vector in particle per plaque forming unit (p.f.u.) ratio was 174 to 1.
E1−/E2A 125 /E3− deficient (temperature sensitive; ts) adenovirus: Temperature-sensitive adenoviruses were generated by subcloning the ts mutation from HSts125 16, 39 into the pBHG11 plasmid. The HSts125 mutation consists of a point mutation that converts a proline into a serine at position 413 of the E2A coding region 39 that renders the adenovirus unable to replicate or to synthesize late viral proteins when grown at 39.5°C. 16 A 6710 bp fragment containing the ts mutation was excised from the HSts125 viral genome (a gift from Dr HS Ginsberg, Columbia University, NY, USA) using the SfiI restriction enzyme and ligated into the SfiI-restricted pBHG11 vector. Cotransfection of 293 cells with this vector and the LacZ/pXCRSV plasmid were then grown at 32°C to generate LacZ/Ad ts adenovirus. Insertion of the ts mutation was confirmed by the lack of cytopathic effect observed in infected 293 cells grown at 40°C. 16 The particle to p.f.u. ratio for this vector was estimated to be 219:1.
Immunosuppression
A transient immune blockade of lymphocytic cells was performed in some animals by a combinational treatment of purified monoclonal antibodies against the rat CD4 (W3/25) 26 and CD45 (MRC OX-22) 27 (provided by Dr S Lightfoot, UT Southwestern Medical School, Dallas, TX, USA) lymphocytic receptors. The animals received 50 g (i.p.) of combined antisera before and 24 h after adenovirus administration.
DREZ surgery and adenovirus administration
Adult female rats were anesthetized using i.p. ketamine (67 mg/kg)/xylazine (6.7 mg/kg). Hemilaminectomies were performed at the T13-L2 vertebral segments. In some animals, the L4-L5 dorsal roots were exposed and transected or lesioned by double crushing and freeze/thawing. All lesions were performed unilaterally on the right side. Each animal received eight injections (0.4 l; 0.25 mm apart and 0.5 mm deep) of individual LacZ adenoviral vectors (5 × 10 6 p.f.u./l) along the L4-L5 dorsal root entry zone using a glass micropipet and a Nanoject injector (Drummond Scientific, Broomall, PA, USA). After injection, the dorsal musculature was sutured, wound clips were applied to skin incision, and prophylactic antibiotic treatment was applied topically to the wound. The animals were placed on a 37°C heat pad and monitored continually until recovery from anesthesia. At the end of the treatment period (ie 7, 21 or 60 days after injection), the animals were killed and perfused transcardially with 1% paraformaldehyde/1.5% glutaraldehyde in buffered saline. The lumbar spinal cord was removed and postfixed before transferring to a 30% sucrose solution for cryoprotection. Tissue sections were cut at 30 m on a cryostat and divided into five alternate sets (ie at 150 m intervals). A set was immediately used for ␤-galactosidase histochemistry and the remaining sections were stored in cryoprotectant solution 40 at −20°C until processed for immunocytochemistry.
␤-Galactosidase histochemistry
The ␤-galactosidase enzyme was detected using the Xgal substrate (4-Cl-5-Br-3-indolyl-B-galatoside). Tissue sections were rinsed in PBS and then incubated in 2 mm MgCl 2 , 5 mm, K 3 Fe(CN) 6 5 mm K 4 Fe(CN) 6 , 0.01% deoxycholate, 0.02% Tween 20 and 1.5 mg/ml of X-gal in PBS for 1 h at 37°C.
Immunocytochemistry
After extensive rinses in phosphate-buffered saline (PBS; pH 7.5), tissue sections were incubated with 5% normal goat serum to reduce nonspecific staining, followed by a 24-h incubation in primary monoclonal antisera. Detection of macrophages/activated microglia (ED-1; 41 1:1000; Chemicon, Temecula, CA, USA) and of CD4 + (W3-25; 26 1:500) and CD8 + (MRC OX-8; 42 1:200) T cells was performed. Visualization was achieved by tissue incubation in biotinylated goat anti-mouse IgG secondary antibodies. Biotin-labeled tissue was further processed using the Vectastain Elite ABC reagents (Vector Laboratories, Burlingame, CA, USA) and developed using a solution of hydrogen peroxide (0.003%) and diaminobenzidine (0.02%). Tissue sections of both control and experimental groups were simultaneously developed using identical incubating solutions. Sections were mounted on gelatinized slides and coverslipped with Permount for light microscopy examination. Double immunofluorescence combining a rabbit anti-␤-galactosidase antibody (1:1000; Cappel Organon Teknika, Weat Chester, PA, USA) and monoclonal antiserum for either glial fibrillary acidic protein (GFAP; 1:500; Chemicon) or the nonphosphorylated form of neurofil-ament H (MSI-32; 1:500; Sternberger Monoclonals, Lutherville, MA, USA) were used for astrocytic and neuronal cell type identification, respectively. Visualization was achieved by simultaneous incubation in Texas Red-labeled goat anti-rabbit and fluorescein-labeled goat antimouse (1:250; Jackson ImmunoResearch Laboratories, West Grove, PA, USA).
Cell counts
Numbers of cells expressing LacZ and ED-1 were determined throughout a 900 m long segment of the L4-L5 lumbar spinal cord by counting all positive cells on six separate tissue sections taken at 150 m intervals. Tissue sections included in the quantitative analysis were those that, qualitatively, showed the greatest number of both LacZ+ and ED−1+ cells within treatment groups. Cell counts were obtained independently by two observers and averaged for statistical analysis.
Statistical analysis
The effects of immunosuppressive treatment, injury (lesioned L4-L5 dorsal roots) and post-transfection time on PWL were evaluated by three factor analysis of variance (ANOVA) (Super ANOVA program; Abacus Concepts, Berkeley, CA, USA). The effects of treatment and injury on both PWL and the number of cells positive for LacZ or ED-1 were evaluated by two factor ANOVA. Data represent the mean ± standard error of the mean (s.e.m.). P values below the 5% probability level were considered significant.
